7.900USD+5.05%Mkt Cap: 15.38M $P/E: Infinity2d ago
Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that lead…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap15.38M $
Enterprise Value8.17M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-17.30M $
Revenue/Share—
Last Price7.900 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS00972G1085
Valuation
P/E (Trailing)Infinity
P/E (Forward)-0.56
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.73
EPS (TTM)0.00
EPS (Forward)-14.00
52W Range
7.04181% of range8.100
52W High8.100 USD
52W Low7.041 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-61.06%
ROA-36.12%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.57M $
CapEx (TTM)—
FCF Margin—
FCF Yield-56.34%
Net Debt-7.00M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.03
Current Ratio0.60
Quick Ratio0.55
Book Value/Sh10.62 USD
Cash/Share3.952 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:40
Split DateMar 31, 2026
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)28.50 USD
Upside (mean)+260.8%
Target Range27.00 USD – 30.00 USD
$27.00+260.8% to mean$30.00
# Analysts2
Ownership
Shares Out.1.95M
Float1.20M
Insiders15.46%
Institutions7.73%
Short Interest
Short Ratio0.4d
Short % Float2.97%
Short % Out.1.56%
Shares Short27.30K
Short (prev mo.)18.00K
Technical
SMA 5010.20 (-22.6%)
SMA 20010.74 (-26.4%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)84.50K
Avg Vol (10d)64.77K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—